Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
501 *
Wed, 8/6/2014,
10:30 AM -
12:20 PM
CC-251
Methods for Safety, Quality, and Benefit-Risk — Contributed Papers
Biopharmaceutical Section
Chair(s): T. Ceesay, Merck
10:35 AM
Mining Association Rules in Clinical Trial Safety Data
—
Li Zhu, Amgen ; Amy Xia, Amgen ; Qi Jiang, Amgen ; Liron Walsh, Amgen ; William Go, Amgen
10:50 AM
Revisiting Risks Ratio and Properties of Corresponding Confidence Intervals
—
Ramin Arani, AstraZeneca ; Ian Hirsch, AstraZeneca
11:05 AM
Multi-Criteria Decision Analysis for Benefit-Risk Analysis and Pharmaceutical Pricing
—
Kao-Tai Tsai ; Bruce Dornseif, Celgene Corporation
11:20 AM
Modeling Censored Stability Data Using Tobit Mixed Models
—
Seth Clark, Merck
11:35 AM
Using a Tolerance Region Approach as a Statistical Quality Control Process for Traditional Chinese Medicine
—
Chinfu Hsiao, National Health Research Institutes ; Yi-Hsuan Lai, National Health Research Institutes
11:50 AM
A Dynamic Bayesian Network Predictive Model with Stochastic Serial Structures in Detecting Safety Signals for Hematologic Responses in Cancer Patients
—
Jagannath Ghosh, Novartis ; D. Das Purkayastha, Novartis
12:05 PM
An Exposition to Integrated Modeling of Patients' Random Early Safety Signals for Effective Detections (Impressed): Cytogenetic, Molecular, and Hematologic Disorders
—
Sandip Acharya, Novartis ; D. Das Purkayastha, Novartis
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department .
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.